Wanxian Lin

机构：Guangzhou First People's Hospital, South China University of Technology, Guangzhou Medical University · ORCID：0009-0000-7293-2294

发表论文 6 篇 · 总被引 112 次 · h-index 4

代表论文

Nanoparticle-mediated blockade of CXCL12/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics (2024 · Acta Biomaterialia · 被引 43)
A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy (2023 · Biomaterials Science · 被引 39)
Immunity/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12/CXCR4 and adenosine-A2AR pathways (2025 · Biomaterials · 被引 19)
Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study (2023 · Academic Radiology · 被引 7)
Acid‐Responsive Disassembly of Nanomedicines for Extracellular Drug Delivery Reversing Glioblastoma Immunosuppressive Microenvironment by Targeting the Adenosine‐A2AR Pathway (2025 · Small · 被引 4)
Nanoparticle-Mediated Blockade of Cxcl12/Cxcr4 Signaling Enhances Glioblastoma Immunotherapy: Monitoring Early Responses with Mri-Radiomics (2023 · SSRN Electronic Journal · 被引 1)